|
|
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views
|
|
|
|
12 Health Care Stocks Moving In Tuesday's Intraday Session
|
|
|
|
Claritev shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.
|
|
|
|
Guggenheim Maintains Buy on Claritev, Lowers Price Target to $38
|
|
|
|
Wells Fargo Maintains Equal-Weight on Claritev, Lowers Price Target to $30
|
|
|
|
Claritev Approves $75M, Five-Year Share Buyback Program
|
|
|
|
Claritev Q4 Earnings Summary & Key Takeaways
|
|
|
|
Claritev Sees FY2026 Sales $980.000M-$1.000B vs $996.146M Est
|
|
|
|
Claritev Q4 EPS $(4.88) Misses $(4.72) Estimate, Sales $246.554M Beat $241.025M Estimate
|
|
|
|
Earnings Scheduled For February 23, 2026
|
|